\documentclass[11pt,twoside]{article}\makeatletter

\IfFileExists{xcolor.sty}%
  {\RequirePackage{xcolor}}%
  {\RequirePackage{color}}
\usepackage{colortbl}
\usepackage{wrapfig}
\usepackage{ifxetex}
\ifxetex
  \usepackage{fontspec}
  \usepackage{xunicode}
  \catcode`⃥=\active \def⃥{\textbackslash}
  \catcode`❴=\active \def❴{\{}
  \catcode`❵=\active \def❵{\}}
  \def\textJapanese{\fontspec{Noto Sans CJK JP}}
  \def\textChinese{\fontspec{Noto Sans CJK SC}}
  \def\textKorean{\fontspec{Noto Sans CJK KR}}
  \setmonofont{DejaVu Sans Mono}
  
\else
  \IfFileExists{utf8x.def}%
   {\usepackage[utf8x]{inputenc}
      \PrerenderUnicode{–}
    }%
   {\usepackage[utf8]{inputenc}}
  \usepackage[english]{babel}
  \usepackage[T1]{fontenc}
  \usepackage{float}
  \usepackage[]{ucs}
  \uc@dclc{8421}{default}{\textbackslash }
  \uc@dclc{10100}{default}{\{}
  \uc@dclc{10101}{default}{\}}
  \uc@dclc{8491}{default}{\AA{}}
  \uc@dclc{8239}{default}{\,}
  \uc@dclc{20154}{default}{ }
  \uc@dclc{10148}{default}{>}
  \def\textschwa{\rotatebox{-90}{e}}
  \def\textJapanese{}
  \def\textChinese{}
  \IfFileExists{tipa.sty}{\usepackage{tipa}}{}
\fi
\def\exampleFont{\ttfamily\small}
\DeclareTextSymbol{\textpi}{OML}{25}
\usepackage{relsize}
\RequirePackage{array}
\def\@testpach{\@chclass
 \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else
  \ifnum \@lastchclass=7 5 \else
   \ifnum \@lastchclass=8 \tw@ \else
    \ifnum \@lastchclass=9 \thr@@
   \else \z@
   \ifnum \@lastchclass = 10 \else
   \edef\@nextchar{\expandafter\string\@nextchar}%
   \@chnum
   \if \@nextchar c\z@ \else
    \if \@nextchar l\@ne \else
     \if \@nextchar r\tw@ \else
   \z@ \@chclass
   \if\@nextchar |\@ne \else
    \if \@nextchar !6 \else
     \if \@nextchar @7 \else
      \if \@nextchar (8 \else
       \if \@nextchar )9 \else
  10
  \@chnum
  \if \@nextchar m\thr@@\else
   \if \@nextchar p4 \else
    \if \@nextchar b5 \else
   \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi
   \fi \fi  \fi  \fi  \fi  \fi  \fi \fi \fi \fi \fi \fi}
\gdef\arraybackslash{\let\\=\@arraycr}
\def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}}
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\def\abbr{}
\def\corr{}
\def\expan{}
\def\gap{}
\def\orig{}
\def\reg{}
\def\ref{}
\def\sic{}
\def\persName{}\def\name{}
\def\placeName{}
\def\orgName{}
\def\textcal#1{{\fontspec{Lucida Calligraphy}#1}}
\def\textgothic#1{{\fontspec{Lucida Blackletter}#1}}
\def\textlarge#1{{\large #1}}
\def\textoverbar#1{\ensuremath{\overline{#1}}}
\def\textquoted#1{‘#1’}
\def\textsmall#1{{\small #1}}
\def\textsubscript#1{\@textsubscript{\selectfont#1}}
\def\textxi{\ensuremath{\xi}}
\def\titlem{\itshape}
\newenvironment{biblfree}{}{\ifvmode\par\fi }
\newenvironment{bibl}{}{}
\newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par }
\newenvironment{citbibl}{}{\ifvmode\par\fi }
\newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi }
\newenvironment{docDate}{}{\ifvmode\par\fi }
\newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi }
\newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par }
\newenvironment{msHead}{\vskip 6pt}{\par}
\newenvironment{msItem}{\vskip 6pt}{\par}
\newenvironment{rubric}{}{}
\newenvironment{titlePart}{}{\par }

\newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}}
\newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}}
\newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}}
\newcolumntype{P}[1]{){\arraybackslash}p{#1}}
\newcolumntype{B}[1]{){\arraybackslash}b{#1}}
\newcolumntype{M}[1]{){\arraybackslash}m{#1}}
\definecolor{label}{gray}{0.75}
\def\unusedattribute#1{\sout{\textcolor{label}{#1}}}
\DeclareRobustCommand*{\xref}{\hyper@normalise\xref@}
\def\xref@#1#2{\hyper@linkurl{#2}{#1}}
\begingroup
\catcode`\_=\active
\gdef_#1{\ensuremath{\sb{\mathrm{#1}}}}
\endgroup
\mathcode`\_=\string"8000
\catcode`\_=12\relax

\usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry}
\usepackage{framed}

\definecolor{shadecolor}{gray}{0.95}
\usepackage{longtable}
\usepackage[normalem]{ulem}
\usepackage{fancyvrb}
\usepackage{fancyhdr}
\usepackage{graphicx}
\usepackage{marginnote}

\renewcommand{\@cite}[1]{#1}


\renewcommand*{\marginfont}{\itshape\footnotesize}

\def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif}

  \pagestyle{fancy}

\usepackage[pdftitle={Management of a Solid Pseudopapillary Tumor of the Pancreas in a Country with Limited Resources: About a Case},
 pdfauthor={}]{hyperref}
\hyperbaseurl{}

	 \paperwidth210mm
	 \paperheight297mm
              
\def\@pnumwidth{1.55em}
\def\@tocrmarg {2.55em}
\def\@dotsep{4.5}
\setcounter{tocdepth}{3}
\clubpenalty=8000
\emergencystretch 3em
\hbadness=4000
\hyphenpenalty=400
\pretolerance=750
\tolerance=2000
\vbadness=4000
\widowpenalty=10000

\renewcommand\section{\@startsection {section}{1}{\z@}%
     {-1.75ex \@plus -0.5ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large\bfseries}}
\renewcommand\subsection{\@startsection{subsection}{2}{\z@}%
     {-1.75ex\@plus -0.5ex \@minus- .2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large}}
\renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}%
     {-1.5ex\@plus -0.35ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\large}}
\renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}%
     {-1ex \@plus-0.35ex \@minus -0.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\normalsize}}
\renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}%
     {1.5ex \@plus1ex \@minus .2ex}%
     {-1em}%
     {\reset@font\normalsize\bfseries}}


\def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt}
 \@tempdima 1.5em \begingroup
 \parindent \z@ \rightskip \@pnumwidth 
 \parfillskip -\@pnumwidth 
 \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par
 \endgroup}
\def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}}
\def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}}
\def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}}
\def\l@subparagraph{\@dottedtocline{5}{10em}{5em}}
\@ifundefined{c@section}{\newcounter{section}}{}
\@ifundefined{c@chapter}{\newcounter{chapter}}{}
\newif\if@mainmatter 
\@mainmattertrue
\def\chaptername{Chapter}
\def\frontmatter{%
  \pagenumbering{roman}
  \def\thechapter{\@roman\c@chapter}
  \def\theHchapter{\roman{chapter}}
  \def\thesection{\@roman\c@section}
  \def\theHsection{\roman{section}}
  \def\@chapapp{}%
}
\def\mainmatter{%
  \cleardoublepage
  \def\thechapter{\@arabic\c@chapter}
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \pagenumbering{arabic}
  \setcounter{secnumdepth}{6}
  \def\@chapapp{\chaptername}%
  \def\theHchapter{\arabic{chapter}}
  \def\thesection{\@arabic\c@section}
  \def\theHsection{\arabic{section}}
}
\def\backmatter{%
  \cleardoublepage
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \setcounter{secnumdepth}{2}
  \def\@chapapp{\appendixname}%
  \def\thechapter{\@Alph\c@chapter}
  \def\theHchapter{\Alph{chapter}}
  \appendix
}
\newenvironment{bibitemlist}[1]{%
   \list{\@biblabel{\@arabic\c@enumiv}}%
       {\settowidth\labelwidth{\@biblabel{#1}}%
        \leftmargin\labelwidth
        \advance\leftmargin\labelsep
        \@openbib@code
        \usecounter{enumiv}%
        \let\p@enumiv\@empty
        \renewcommand\theenumiv{\@arabic\c@enumiv}%
	}%
  \sloppy
  \clubpenalty4000
  \@clubpenalty \clubpenalty
  \widowpenalty4000%
  \sfcode`\.\@m}%
  {\def\@noitemerr
    {\@latex@warning{Empty `bibitemlist' environment}}%
    \endlist}

\def\tableofcontents{\section*{\contentsname}\@starttoc{toc}}
\parskip0pt
\parindent1em
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\newenvironment{reflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemsep}{0pt}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\itshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{sansreflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\itemsep}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\upshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{specHead}[2]%
 {\vspace{20pt}\hrule\vspace{10pt}%
  \phantomsection\label{#1}\markright{#2}%

  \pdfbookmark[2]{#2}{#1}%
  \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}%
  }{}
      \def\TheFullDate{1970-01-01 (revised: 01 January 1970)}
\def\TheID{\makeatother }
\def\TheDate{1970-01-01}
\title{Management of a Solid Pseudopapillary Tumor of the Pancreas in a Country with Limited Resources: About a Case}
\author{}\makeatletter 
\makeatletter
\newcommand*{\cleartoleftpage}{%
  \clearpage
    \if@twoside
    \ifodd\c@page
      \hbox{}\newpage
      \if@twocolumn
        \hbox{}\newpage
      \fi
    \fi
  \fi
}
\makeatother
\makeatletter
\thispagestyle{empty}
\markright{\@title}\markboth{\@title}{\@author}
\renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@
\belowdisplayskip \abovedisplayskip
\abovedisplayshortskip \z@ plus2\p@
\belowdisplayshortskip 4\p@ plus2\p@ minus2\p@
\def\@listi{\leftmargin\leftmargini
               \topsep 2\p@ plus1\p@ minus1\p@
               \parsep 2\p@ plus\p@ minus\p@
               \itemsep 1pt}
}
\makeatother
\fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm}
\fancyhf{} 
\setlength{\headheight}{14pt}
\fancyhead[LE]{\bfseries\leftmark} 
\fancyhead[RO]{\bfseries\rightmark} 
\fancyfoot[RO]{}
\fancyfoot[CO]{\thepage}
\fancyfoot[LO]{\TheID}
\fancyfoot[LE]{}
\fancyfoot[CE]{\thepage}
\fancyfoot[RE]{\TheID}
\hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true}
\fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}}

\date{}
\usepackage{authblk}

\providecommand{\keywords}[1]
{
\footnotesize
  \textbf{\textit{Index terms---}} #1
}

\usepackage{graphicx,xcolor}
\definecolor{GJBlue}{HTML}{273B81}
\definecolor{GJLightBlue}{HTML}{0A9DD9}
\definecolor{GJMediumGrey}{HTML}{6D6E70}
\definecolor{GJLightGrey}{HTML}{929497} 

\renewenvironment{abstract}{%
   \setlength{\parindent}{0pt}\raggedright
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
   \textcolor{GJBlue}{\large\bfseries\abstractname\space}
}{%   
   \vskip8pt
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
}

\usepackage[absolute,overlay]{textpos}

\makeatother 
      \usepackage{lineno}
      \linenumbers
      
\begin{document}

             \affil[1]{  }

\renewcommand\Authands{ and }

\date{\small \em Received: 1 January 1970 Accepted: 1 January 1970 Published: 1 January 1970}

\maketitle


\begin{abstract}
        


Pseudo-papillary and solid tumors of the pancreas are rare tumors of uncertain etiopathogenesis. We report the difficulty of managing a pseudopapillary tumor in our country, where resources were limited. Our objective was to discuss therapeutic management about the literature.Observation: This is a 19-year-old young woman. View in consultation for chronic abdominal pain, without neoplastic family history. Abdominal palpation revealed an intra-abdominal mass syndrome. Abdominal computed tomography had shown a heterogeneous solid cystic tumor mass in the corporeal-caudal region, well encapsulated, well limited, without infiltration, without peripheral lymph nodes with homogeneous contrast uptake, without vascular invasion or remote secondary location. We are to decide on pancreatic enucleation by laparotomy. The diagnosis was confirmed a histological study of the surgical specimen. The evolution was favorable remote non metastasis or recurrence after two years of follow-up.

\end{abstract}


\keywords{}

\begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) 
\textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark}
\end{textblock*}

\begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) 
\textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}}
\end{textblock*}


\begin{textblock*}{10cm}(1.05cm,3cm)
{{\textit{CrossRef DOI of original article:}} \underline{}}
\end{textblock*}\let\tabcellsep& 	 	 		 \par
Observation: This is a 19-year-old young woman. View in consultation for chronic abdominal pain, without neoplastic family history. Abdominal palpation revealed an intraabdominal mass syndrome. Abdominal computed tomography had shown a heterogeneous solid cystic tumor mass in the corporeal-caudal region, well encapsulated, well limited, without infiltration, without peripheral lymph nodes with homogeneous contrast uptake, without vascular invasion or remote secondary location. We are to decide on pancreatic enucleation by laparotomy. The diagnosis was confirmed a histological study of the surgical specimen. The evolution was favorable remote non metastasis or recurrence after two years of follow-up. Keywords: surgery; women; young adult; prognosis; pancreatic tumors. 
\section[{I. INTRODUCTION}]{I. INTRODUCTION}\par
Solid pseudopapillary tumor of the pancreas is a relatively rare tumor, most often found in young women \hyperref[b0]{[1,}\hyperref[b1]{2]}. In general, it is a tumor with a low potential for malignancy  {\ref [3.4]}. It is a tumor with clinical polymorphism. These tumors are now recognized with increased frequency thanks to the progress and improvement of imaging techniques. We report a case of pseudo-papillary tumor of the pancreas, which was treated by pancreatic enucleation, in a 19-year-old young woman seen at the Joseph Ravoahangy Andrianavalona University Hospital of Antananarivo (CHU-JRA). Our objective was to discuss therapeutic management compared to the literature. 
\section[{II. OBSERVATION}]{II. OBSERVATION}\par
Young   {\ref 1}).\par
Surgical treatment was performed by midline supraumbilical laparotomy; on exploration: there was no peritoneal carcinomatosis. After the opening of the posterior cavity of the omentums, we found a rounded and well-defined tumor sitting at the corporate-caudal level of the pancreas with no visible lymphadenopathy. A frozen section histological examination was performed, showing a well encapsulated tumor. A lumpectomy by pancreatic enucleation was performed (Figure \hyperref[fig_1]{2}).\par
The anatomopathological study of the surgical specimens showed a brownish piece, firm, well encapsulated, measuring 12x8x7 cm, of heterogeneous brownish-white content with necrotichemorrhagic changes and a well-encapsulated lymph node of 1cm long axis without tumor invasion or vascular embolism. On histological examination, it was a solid pseudopapillary tumor of the pancreas with reactive lymph node hyperplasia.\par
The postoperative follow-up was simple after a postoperative hospital stay of seven days without adjuvant therapy without complications of pancreatic fistula. With a follow-up of 2 years, the patient is in good general condition with no clinical or CT scan recurrence. 
\section[{III. DISCUSSION}]{III. DISCUSSION}\par
The pseudopapillary tumor of the pancreas is a rare exocrine pancreatic tumor in the order of 2\% and accounts for less than 5\% of cystic tumors of the pancreas \hyperref[b3]{[4]}. It was described by Frantz in 1959 \hyperref[b4]{[5]}. They are low-grade malignant tumors composed of poorly cohesive uniform epithelial cells forming solid, pseudopapillary structures. \hyperref[b3]{[4]}. There are less than 1000 cases reported in the literature, mainly in the form of isolated instances. Similar to our patient, it is a predominantly female tumor with a sex ratio of 0.18. It occurs at a young age, with an average age of 29.3 years \hyperref[b5]{[6]}. Its pathogenesis remains poorly understood; its female predominance may be linked to hormonal factors \hyperref[b6]{[7]}. Most of the series in the literature find a black or Asian ethnic origin, such as our patient  {\ref [6.8]}.\par
The preferential localization of this tumor is corporeal-caudal in 64\% of cases. However localizations at the level of the head of the pancreas or even extra-pancreatic can be found. \hyperref[b0]{[1,}\hyperref[b1]{2]}. In our case, the tumor was found in the body of the pancreas. It is a solid mass delimited by a capsule and associating areas of hemorrhage, necrosis, and calcifications. Symptoms are generally not specific, often incidental discovery of an abdominal mass, or abdominal pain with signs of digestive compression, depending on the size of the tumor \hyperref[b8]{[9]} which explains the symptoms of our patient by compression. There are no specific biological signs of the pseudopapillary tumor of the pancreas. The immunohistochemistry examination, coupled with the histological examination, poses the diagnosis of certainty of the disease \hyperref[b9]{[10]}. Immunohistochemistry is a very efficient examination but not routinely available in our country. Pancreatic pseudopapillary tumors are usually located in the tail of the pancreas. It is a large tumor containing solid and cystic components due to necrosis, hemorrhage, and cystic degeneration. The radiological aspect of the cancer shows a well-encapsulated, heterogeneous complex mass with solid and cystic components \hyperref[b0]{[1]}. Abdominal ultrasound, most often finds a well-limited cystic mass with regular contours, poorly vascularized, with heterogeneous contents and no interior partitions, such as our case. Computed tomography is the most requested examination and better than ultrasound in terms of precision, which finds the same characteristics on ultrasound with partial enhancement in the periphery after injection of the contrast product without invasion of neighboring organs and possible intra-tumoral hemorrhage and calcification consistent with our case \hyperref[b0]{[1]}.\par
Despite the superiority of MRI over computed tomography and ultrasound, our patient could not benefit from magnetic resonance imaging because of the very high cost. In addition, the clinical symptoms associated with ultrasound and London Journal of Medical and Health Research computed tomography were sufficient to establish the indication for primary surgery.\par
We proceeded to surgery alone without preoperative biopsy, thanks to anamnestic, clinical, and radiological evidence. According to the literature, the reference treatment is complete resection by cephalic duodenal-pancreatectomy, if the tumor is located in the head or body and partial pancreatectomy with partial splenectomy in the event of a tumor located in the tail of the pancreas, especially in case of capsular rupture or invasion of neighboring organs \hyperref[b1]{[2]}, In our case, a spontaneous, an impromptu histological examination was done intraoperatively which showed a well-encapsulated tumor which motivated us to perform pancreatic enucleation.\par
The advantage of our choice allows decreasing the morbidity and mortality compared to the cephalic duodenal pancreatectomy in front of a wellencapsulated tumor without capsular rupture or lymph node invasion. The risk of tumor recurrence varies from 0 to 14\% \hyperref[b11]{[11]} ; with a follow-up of 2 years, no reproduction was reported in our case. According to the literature, the place of chemotherapy and radiotherapy is in the managing of unresectable tumors with lymph nodes or distant metastasis \hyperref[b12]{[12]}. Even in metastasis, the prognosis for long-term survival is good \hyperref[b5]{[6]}. In our patient, we did not perform chemotherapy. 
\section[{IV. CONCLUSION}]{IV. CONCLUSION}\par
The pseudopapillary tumor of the pancreas is a relatively rare, the symptomatology of which is not specific. The diagnosis of certainty is based on histology coupled with immunohistochemistry.\par
Imaging examinations make it possible to locate and help with tumor resection. A pancreatic enucleation can be practiced before a solid pseudo-papillary tumor of the pancreas, well encapsulated without lymph node invasion or capsular rupture on histological examination. With a low recurrence rate and a good survival prognosis.  \begin{figure}[htbp]
\noindent\textbf{16}\includegraphics[]{image-2.png}
\caption{\label{fig_0}Figure 1 : 6}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{2}\includegraphics[]{image-3.png}
\caption{\label{fig_1}Figure 2 :}\end{figure}
 			\label{foot_0}\footnote{\label{foot_0} © 2023 Great ] Britain Journals Press Volume 23 | Issue 6 | Compilation 1.0} 		 		\backmatter  			  				\begin{bibitemlist}{1}
\bibitem[ London Journal of Medical and Health Research]{b10}\label{b10} 	 		\textit{},  	 	 		\textit{London Journal of Medical and Health Research}  		 	 
\bibitem[Yao and Song ()]{b5}\label{b5} 	 		‘A Review of Clinicopathological Characteristics and Treatment of Solid Pseudopapillary Tumor of the Pancreas with 2450 Cases in Chinese Population’.  		 			J Yao 		,  		 			H Song 		.  	 	 		\textit{BioMed Research International}  		2020. 2020 p. .  	 
\bibitem[Law et al. ()]{b11}\label{b11} 	 		‘A Systematic Review of Solid-Pseudopapillary Neoplasms: Are These Rare Lesions?’.  		 			J K Law 		,  		 			A Ahmed 		,  		 			V K Singh 		,  		 			V S Akshintala 		,  		 			M T Olson 		,  		 			S P Raman 		.  	 	 		\textit{Pancreas}  		2014. 43 p. .  	 
\bibitem[Hu et al. ()]{b8}\label{b8} 	 		‘Asymptomatic versus symptomatic solid pseudopapillary tumors of the pancreas: clinical and MDCT manifestations’.  		 			S Hu 		,  		 			H Zhang 		,  		 			X Wang 		,  		 			Z Sun 		,  		 			Y Ge 		,  		 			G Yan 		.  	 	 		\textit{Cancer Imaging}  		2019. 19 p. 13.  	 
\bibitem[Ji et al. ()]{b12}\label{b12} 	 		‘Management of a Malignant Case of Solid Pseudopapillary Tumor of Pancreas: A Case Report and Literature Review’.  		 			S Ji 		,  		 			J Xu 		,  		 			B Zhang 		,  		 			Y Xu 		,  		 			C Liu 		,  		 			J Long 		.  	 	 		\textit{Pancreas}  		2012. 41 p. .  	 
\bibitem[Maffuz et al. ()]{b6}\label{b6} 	 		‘Preoperative gemcitabine for unresectable, solid pseudopapillary tumor of the pancreas’.  		 			A Maffuz 		,  		 			Thé De 		,  		 			F Bustamante 		,  		 			J A Silva 		,  		 			S Torres-Vargas 		.  	 	 		\textit{The Lancet Oncology}  		2005. 6 p. .  	 
\bibitem[Miloudi et al. ()]{b7}\label{b7} 	 		‘Pseudopapillary and solid tumor of the pancreas’.  		 			N Miloudi 		,  		 			S Sabbagh 		,  		 			M A Attaoui 		,  		 			Ben Abid 		,  		 			S Gharbi 		,  		 			L Khalfallah 		,  		 			MT 		.  		 \xref{http://dx.doi.org/10.1016/j.jcco.2013.10.001}{10.1016/j.jcco.2013.10.001}.  		 \url{https://doi.org/10.1016/j.jcco.2013.10.001}  	 	 		\textit{JCC Open}  		2013. 1 p. .  	 
\bibitem[Elk et al. ()]{b9}\label{b9} 	 		‘Pseudopapillary and solid tumor of the pancreas’.  		 			Alahyane A Elk 		,  		 			H Charhi 		,  		 			O Qamous 		,  		 			H El 		,  		 			Y Zoubier 		.  	 	 		\textit{Medical Morocco}  		2013. 2010. 32  (1) .  	 
\bibitem[Jakhlal et al. ()]{b1}\label{b1} 	 		‘Pseudopapillary and solid tumor of the pancreas: about a case and review of the literature’.  		 			N Jakhlal 		,  		 			N Njoumi 		,  		 			H Hachi 		,  		 			A Bougtab 		.  	 	 		\textit{Pan Afr Med J}  		2016. 24.  	 
\bibitem[Gandhi et al. ()]{b0}\label{b0} 	 		‘Solid pseudopapillary tumor of the pancreas: radiological and surgical review’.  		 			D Gandhi 		,  		 			P Sharma 		,  		 			K Parashar 		,  		 			P S Kochar 		,  		 			K Ahuja 		,  		 			H Sawhney 		.  	 	 		\textit{Clinical Imaging}  		2020. 67 p. .  	 
\bibitem[Kim et al. ()]{b2}\label{b2} 	 		‘Surgical treatment of solid pseudopapillary neoplasms of the pancreas and risk factors for malignancy’.  		 			M J Kim 		,  		 			D W Choi 		,  		 			S H Choi 		,  		 			J S Heo 		,  		 			J Y Sung 		.  	 	 		\textit{British Journal of Surgery}  		2014. 101 p. .  	 
\bibitem[Frantz ()]{b4}\label{b4} 	 		‘Tumorsof the pancreas’.  		 			V K Frantz 		.  	 	 		\textit{Atlas of tumor pathology, section VII},  		 (Washington DC)  		1959. Armed Forces Institute of Pathology. p. 28.  	 	 (Paper 27) 
\bibitem[Bosman ()]{b3}\label{b3} 	 		‘World Health Organization, International Agency for Research on Cancer’.  		 			F T Bosman 		.  	 	 		\textit{WHO classification oftumors of the digestive system. 4th},  		2010. International Agency for Research on Cancer.  	 
\end{bibitemlist}
 			 		 	 
\end{document}
